spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

WADA to ban non-diagnostic use of carbon monoxide

The World Anti-Doping Agency (WADA) will add the non-diagnostic use of carbon monoxide to its prohibited methods list from next year, the organisation said.

The gas is used in low doses to help measure critical blood metrics in athletes, especially haemoglobin levels, but there have been suggestions that repeated inhalation can be used to improve athletic performance.

Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
The International Cycling Union (UCI) has banned the use of carbon monoxide outside of a medical facility, and in a press release on Wednesday WADA said its use could increase erythropoiesis – the process of creating new red blood cells.

“The use of carbon monoxide for diagnostic purposes, such as total haemoglobin mass measurements or the determination of pulmonary diffusion capacity, is not prohibited,” WADA added.

“The current wording was chosen to differentiate between illicit use and the intake resulting from natural combustion processes (e.g. smoking), the environment (e.g. exhaust gases) or diagnostic procedures.”

An investigation published by website Escape Collective during this year’s Tour de France alleged several teams used carbon monoxide rebreather devices to optimise altitude training.

Hot this week

Daewoong Pharmaceutical Holds Talks with Saudi Officials on Bioindustry Cooperation

Daewoong Pharmaceutical said on October 17 that it met...

Novo Nordisk chair and independent directors to exit in strategy dispute

The chair of Wegovy maker Novo Nordisk and six...

Hologic to go private in up to $18.3 billion deal backed by Blackstone, TPG

Medical diagnostics firm Hologic has agreed to be acquired...

China’s Innovent signs $11.4 billion cancer therapy deal with Japan’s Takeda

-China’s Innovent Biologics said on Wednesday it had signed...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img